Clinical Trials Browser

Phase NA × gadolinium ethoxybenzyl DTPA × Gastrointestinal × Clear all

NCT02156739 2025-12-22

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Phase NA Active not recruiting

Gastrointestinal

Digestive System Diseases, Carcinoma, Hepatocellular